DW-MSC(Daewoong Pharmaceutical)

N/A

Report date: 2026/01/14 20:00:44

Base Information

Drug NameDW-MSC(Daewoong Pharmaceutical)
Drug Alias Nameallogeneic mesenchymal stem cellDWP 710DWP-710
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)DementiaStroke +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndonesia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaewoong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDementiaStrokeBrain Diseases +[5] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Rhinitis, Allergic, SeasonalCoronavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A